ReviewCurrent urology reports2017
The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas.
Review in Current urology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.
- Safety and efficacy of transcatheter arterial embolization in renal angiomyolipomas: a systematic review and meta-analysis.BMC nephrology · 2025Pooled it
- Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis.The Journal of international medical research · 2019Pooled it
- Predictors of Hemorrhage and Re-Intervention in Renal Angiomyolipoma Following Transcatheter Arterial Embolization.Journal of clinical medicine · 2025Article
- Wunderlich Syndrome Caused by Spontaneous Rupture of Renal Angiomyolipoma in the Third Trimester of Pregnancy: Endovascular Management With Fetal Preservation-A Case Report and Literature Review.Clinical case reports · 2025Article
- Efficacy of iodized oil in emergency ultraselective arterial embolization for fatal massive hemorrhage due to renal angiomyolipoma: a single-center retrospective cohort study.Translational andrology and urology · 2024Article
- Primary robot-assisted laparoscopic partial nephrectomy for hemorrhage secondary to angiomyolipoma: a retrospective study from a large tertiary hospital in China.Scientific reports · 2024Article
- Comparison of Superselective Renal Artery Embolization versus Retroperitoneal Laparoscopic Partial Nephrectomy in Ruptured Hemorrhagic Renal Angiomyolipoma: A Single-Center Study.Diseases (Basel, Switzerland) · 2024Article
- Introduction to interventional oncology: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.Pediatric blood & cancer · 2023Article
- Selective arterial embolization of renal angiomyolipoma: comparing ethanol-lipiodol emulsion and polyvinyl alcohol particles as embolic agents.Diagnostic and interventional radiology (Ankara, Turkey) · 2023Article
- Endovascular management of renal angiomyolipomas: Do coils have a benefit in terms of clinical success rates?Diagnostic and interventional radiology (Ankara, Turkey) · 2022Article
- Radiologic and clinical results of transarterial ethanol embolization for renal angiomyolipoma.European radiology · 2021Article
- Endovascular Interventional Radiology of the Urogenital Tract.Medicina (Kaunas, Lithuania) · 2021Review
- Different Treatments of Symptomatic Angiomyolipomas of the Kidney: Two Case Reports.Journal of kidney cancer and VHL · 2021Article
- Use of microspheres in embolization for unruptured renal angiomyolipomas.Open medicine (Warsaw, Poland) · 2021Article
- Urgent Transcatheter Arterial Embolization for Wunderlich Syndrome With Hypovolemic Shock Secondary to Ruptured Renal Angiomyolipoma.Frontiers in surgery · 2021Article
- Transcatheter arterial embolization for unruptured renal angiomyolipoma using a 1.8-Fr tip microballoon catheter with a mixture of ethanol and Lipiodol.CVIR endovascular · 2020Article
- A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation.Annals of translational medicine · 2019Article
- Can we predict the existence of extrarenal feeders to renal angiomyolipomas?European radiology · 2019Article
- Percutaneous microwave ablation of renal angiomyolipomas in tuberous sclerosis complex to improve the quality of life: preliminary experience in an Italian center.La Radiologia medica · 2019Article
- Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage.International urology and nephrology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewAlthough benign, renal angiomyolipoma (AML) may lead to serious complications without appropriate management. The purpose of this review is to describe the role of and evidence for interventional radiology techniques in the management of patients with AML. RECENT
findingsFor patients with renal masses and non-diagnostic imaging studies, image-guided percutaneous biopsy is found to be highly accurate and useful in directing patient management. Once the diagnosis of AML has been made based on either imaging or biopsy, arterial embolization of tumors that are symptomatic or >4 cm has been demonstrated to reduce the risk of hemorrhage as well as tumor size. Percutaneous ablation devices have been proposed as alternative strategies but remain investigational. The utility of interventional radiology techniques including percutaneous core needle biopsy and prophylactic super-selective arterial embolization is safe and effective management strategies for patients presenting with AML tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.